Skip to main content

Stereotaxis, Inc.

For the period ended Mar 31, 2026. Filed May 13, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 13, 2026

STXS$1.03-9.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Statements of Cash Flows

Three Months Ended March 31,
(in thousands)20262025
Cash flows from operating activities
Net loss$(5,861)$(5,823)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation159156
Amortization of intangibles236214
Loss on revaluation of contingent consideration756502
Non-cash lease expense(4)-
Stock-based compensation2,1102,535
Changes in operating assets and liabilities:
Accounts receivable543(500)
Inventories(928)(1,481)
Prepaid expenses and other current assets(599)760
Other assets(52)9
Accounts payable(49)852
Accrued liabilities(587)5
Deferred revenue834992
Net cash used in operating activities(3,442)(1,779)
Cash flows from investing activities
Purchase of property and equipment(79)-
Net cash used in investing activities(79)-
Cash flows from financing activities
Proceeds from issuance of stock4,85332
Equity issuance costs(137)-
Net cash provided by financing activities4,71632
Net increase (decrease) in cash, cash equivalents, and restricted cash1,195(1,747)
Cash, cash equivalents, and restricted cash at beginning of period13,42112,436
Cash, cash equivalents, and restricted cash at end of period$14,616$10,689
Supplemental disclosure of cash flow information:
Purchase of property and equipment included in accounts payable$17$23
Reconciliation of cash, cash equivalents, and restricted cash to consolidated balance sheet as of March 31st:
Cash and cash equivalents$14,616$10,601
Restricted cash - current-88
Total cash, cash equivalents, and restricted cash$14,616$10,689
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.